Opthea Limited (OPT) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Opthea Limited  (NASDAQ: OPT)


Opthea Limited's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Opthea Limited's ROI in the fourth quarter of 2025?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Opthea Limited's return on investment (ROI) in its fourth quarter of 2025

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
IV. Quarter
Y / Y Investment Change TTM - - - - 27.61 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -201 -201 -201 -201 125
Return On Investment (TTM) - - - - -295.22 %
OPT's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - 17.68 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -163 -220 -220 -220 -220

OPT Company Profile >> Back to OPT Roi Comparisons >> See Annual OPT Return On Investment



Return On Investment OPT's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Opthea Limited's IV. Quarter Investments $ -201 Millions OPT's Balance sheet
Opthea Limited's IV. Quarter Income $ -163 Millions Quarterly OPT's Income Statement
OPT's Income by Division See OPT's Income by Division


OPT Annual Return On Investment (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022		 (Jun 30 2021)
2021
Total Investments in Millions -201 -76 -6 48 138
Y / Y Investment Growth - - - -65.13 % -
Net Income in Millions -163 -220 -143 -93 -45
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - -193.35 % -32.94 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OPT's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for OPT's Competitors
Subscribers only: Roi for Opthea Limited's Suppliers
Subscribers only: Return On Investment for OPT's Customers

Other Ratios
OPT's Roa OPT's Inventory Turnover Ratio OPT's Growth Rates OPT's Dividend Statistics
OPT's Profitability Ratios OPT's Asset Turnover Ratio OPT's Dividend Growth
OPT's Roe OPT's Valuation Ratios OPT's Financial Strength Ratios OPT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI
Capforce Inc   177.96 %
Emmis Acquisition Corp   140.55 %
Oak Woods Acquisition Corp  106.75 %
Coherus Oncology inc   105.87 %
Interpace Biosciences Inc   102.53 %
Rigel Pharmaceuticals Inc  92.61 %
Cytomx Therapeutics Inc   80.43 %
Seres Therapeutics Inc   75.04 %
Gridai Technologies Corp  75.01 %
Earth Science Tech Inc   74.07 %
Stablecoin Development Corporation  66.04 %
Novavax inc   56.96 %
Exelixis Inc   55.73 %
Biomx Inc  53.39 %
Adma Biologics Inc   49.11 %
Medinotec Inc   48.14 %
Abeona Therapeutics Inc   46.96 %
Synlogic Inc   46.41 %
Dariohealth Corp   45.05 %
Idexx Laboratories Inc  44.34 %
Entera Bio Ltd   43.13 %
Puma Biotechnology Inc   42.38 %
Agios Pharmaceuticals Inc   41.91 %
Siga Technologies Inc  38.92 %
Ptc Therapeutics inc   38.85 %
Mettler toledo International Inc   36.69 %
Edwards Lifesciences Corporation  35.59 %
Minerva Neurosciences Inc   34.19 %
Arcutis Biotherapeutics Inc   34.15 %
Longduoduo Co Ltd  33.92 %

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.